SCHEDULE 13G/A: Rosalind Entities Disclose 7.2% Passive Stake in MediWound Ltd. via Latest SEC Filing Amendment
Beneficial Ownership Disclosure
Rosalind Advisors, Inc., Rosalind Master Fund L.P., and associated individuals have disclosed a combined 7.2% passive beneficial ownership stake in MediWound Ltd., totaling 791,315 common shares, as of December 31, 2024.
Summary
- Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively reported beneficial ownership of 791,315 common shares of MediWound Ltd.
- This aggregate amount includes 628,050 shares of common stock and 163,265 shares issuable upon the exercise of warrants.
- The reported 791,315 shares represent 7.2% of MediWound Ltd.'s common stock outstanding, calculated based on 10,786,423 shares as of August 15, 2024.
- A blocker provision on the warrants limits their exercise, preventing beneficial ownership from exceeding 9.99% of the Common Stock, meaning the actual number of beneficially owned shares after giving effect to these blockers is less than the reported aggregate.
- The reporting persons state that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of MediWound Ltd.
Sentiment
Score: 5
Explanation: Neutral. This is a standard regulatory disclosure of a passive ownership stake and does not contain information that would inherently be positive or negative for the company's operations or financial performance. It simply updates the market on a significant shareholder's position.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant passive ownership stake by Rosalind entities, confirming their position as a major shareholder.
Key Dates
| Date | Description |
|---|---|
| 2024-08-15 | Date as of which 10,786,423 shares of MediWound Ltd.'s common stock were outstanding, used for percentage calculation. |
| 2024-08-29 | Date of F3 filing, which reported the outstanding shares. |
| 2024-12-31 | Date of event which requires filing of this statement (ownership snapshot date). |
| 2025-02-11 | Date of signing and filing of the Schedule 13G Amendment No. 5. |
Keywords
MediWound Ltd., Rosalind Advisors, Rosalind Master Fund, SEC filing, Schedule 13G, beneficial ownership, common shares, warrants, passive investment, M68830104
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.